Navigation Links
Synteract Senior Director Olivia Montano Honored as One of the PharmaVOICE 100
Date:8/2/2012

SAN DIEGO, Aug. 2, 2012 /PRNewswire/ -- Synteract, a leading full service contract research organization (CRO), is proud to announce Olivia Montano, senior director of clinical data management at Synteract, as one of the named recipients of the 2012 PharmaVOICE 100 award. The award given by PharmaVOICE magazine recognizes the top 100 thought leaders and innovators in the Life Sciences industry.  

(Logo:  http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)

Montano, who was nominated by industry peers, is known for her contributions as a mentor and team leader, and for her significant impact on the high quality standards of both Synteract and the industry as a whole. Since joining Synteract in 1999 as one of its first 30 employees, she has been instrumental in the development and growth of its data management department, and most recently instituted an internal training program of 26 sessions for the SCDM clinical data manager exam.  An active participant in biotechnology and pharmaceutical industry associations, Montano has been a subject matter expert for electronic data capture standards. She contributed to several chapters for the SCDM manual "Good Clinical Data Management Practices" and collaborated with CDISC as a subject matter expert on the CDASH guidelines and user guide.

"As senior director of clinical data ­management at Synteract Inc., Olivia Montano is having a significant impact on the high-quality standards of both her CRO and the industry as a whole," said Taren Grom, editor, PharmaVOICE. "She has built an incredible data management department at Synteract, and is drawing on her well-rounded background to set new and improved standards. Her dedication to the data field and to helping her colleagues and peers realize their goals are just a few of the reasons Ms. Montano is being recognized as a 2012 PharmaVOICE 100 honoree."

Honorees were identified in the July/August 2012 issue of PharmaVOICE magazine. The PharmaVOICE 100 are selected based on comprehensive submissions from industry professionals describing how nominees inspired or motivated them or affected positive changes as well as other factors, such as community and philanthropic activities. The annual award competition receives thousands of nominations each year from PhamaVOICE readers.

Wendel Barr, CEO of Synteract, says, "It is a pleasure to see Olivia recognized in this way. Olivia continues to maintain a big picture perspective as well as strong attention to detail in all she does. Olivia would tell you her biggest accomplishment is mentoring others to achieve their own potential to become great data managers. Her ongoing dedication to developing and supporting her team contributes to the efficiency and quality clients can expect from Synteract. She is most deserving of this industry recognition."

About PharmaVOICE (http://www.pharmavoice.com)
PharmaVOICE is written and designed to deliver the views, opinions, and insights of executives who are shaping the direction of the dynamic life-sciences industry. PharmaVOICE reaches more than 29,000 BPA qualified subscribers and more than 100,000 users with its digital edition, providing multiple perspectives on business challenges, trends, and topics. Its editorial content sparks dialog, initiates debate, and opens the lines of communication to facilitate and improve business-to-business relationships.

About Synteract (www.synteract.com)
Synteract is a full-service contract research organization with a successful 17-year track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. With its "Shared Work – Shared Vision" philosophy Synteract provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data so clients get to decision points faster. Headquartered in California, with offices in North Carolina and the Czech Republic, Synteract delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology.

CONTACT:
Beth Walsh
beth@clearpointagency.com 
858-724-2500


'/>"/>
SOURCE Synteract, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Synteract and Rempex Partner in "Great Strides" Walk to Support Cystic Fibrosis Cure
2. Synteract Sponsoring and Presenting at Outsourcing in Clinical Trials Southeast Conference
3. Medical Guardian Announces Social Media Partnership with Senior Citizen Charity
4. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
5. Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
6. Global BioClinical Welcomes Jennifer Maas as Senior Consultant
7. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
8. Onyx Pharmaceuticals Names John E. Osborn Senior Vice President, Global Corporate Affairs
9. CSS Health Technologies Hires Industry Leader as New Senior Vice President of Sales
10. Bausch + Lomb Commences Tender Offer of Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3 and U07190AA6)
11. Biomet Amends Tender Offer of its 10 3/8 %/11 1/8% Series Senior Toggle Notes due 2017 (CUSIP Nos. 090613AD2, 550785AC3 and U55004AB8)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
Breaking Medicine News(10 mins):